Vitamin K Segmentation
Application (Osteoporosis, Vitamin K Dependent Clotting Factor Deficiency (VKCFD), Prothrombin deficiency, Vitamin K Deficiency Bleeding (VKDB), Dermal Application)
The osteoporosis segment is projected to hold a significant proportion of the revenue share accounting for 22% of the vitamin K market during the forecast period. Additionally, this segment is growing due to the increasing osteoporotic patients, aging global population, and postmenopausal women who are prone to suffer from bone-related complications. This propels the demand for interventions that support bone health, including vitamin K supplements, further driving the market expansion.
Moreover, individuals with osteoporosis exhibit brittle bones and often have inadequate levels of vitamin K. Furthermore, healthcare specialists commonly advise the use of vitamin K supplements to enhance bone density and enhanced body metabolism. In 2022, the National Library of Medicine stated that osteoporosis is estimated to affect more than 30 million persons in Europe and a similar number of individuals in the U.S.
Product Type (Vitamin K1, Vitamin K2)
The vitamin K2 segment is expected to account for a significant revenue share in the vitamin K market during the forecast period. This segment is also anticipated to continue its dominance due to the rising use of vitamin k2 in bone development, blood coagulation, vascular protection, and many more. Vitamin K2 is an incredibly complete ingredient that is important at all life stages, from pregnancy and early life to old age. This is popularly known as menaquinone and is mainly found in dairy, fermented foods, and animal products.
It is beneficial especially for preventing heart-related diseases, bone health, regulating blood sugar, promoting proper brain functioning, and enhancing the overall metabolism of the body. In October 2022, Kappa Bioscience, a leading manufacturer of vitamin K2 under the brand name K2Vital, is introducing the first USDA organic-certified all-trans, all-bioactive vitamin K2-MK7 for oil-based health applications in the US market.
Route of Administration (Oral, Topical, Parenteral)
The oral segment is anticipated to garner a major share of the vitamin K market during the predicted period. Supplements in the form of pills, tablets, capsules, powders, and liquid are easily accessible and more convenient to consume compared to invasive and topical applications. Oral formulations are cheaper to create and distribute, making them affordable for consumers and healthcare providers. In recent years, more parents have declined newborn vitamin K vaccinations. Due to this, more babies have late-onset vitamin K deficient hemorrhage. According to this APP recommendation, all newborns weighing greater than 1500 g should get 1 mg of Vitamin K intramuscularly within 6 hours of birth.
Our in-depth analysis of the vitamin K market includes the following segments:
|
Product Type |
|
|
Route of Administration |
|
|
Application |
|
